Coronavirus prevention vaccine dose is no worse. Hyderabad-based India has made some significant changes to its biotech vaccine collection so that the remaining dose can be used for 28 days instead of four. However, it is important to be able to store the remaining dose between 2 and 8 degrees. This change will be reflected in the new list to prevent the destruction of the vaccine layer. India Biotech distributes the vaccine directly to the United States, as it would be safe.

Covasin was developed by an Indian biotechnology company created in collaboration with scientists from IVMR and NIV of Pune.

One sound contains 20 doses. If the vial is open, all 20 doses should be administered within four hours. If it does not, the remaining dose is wasted. For this reason, doses of covshield and covasin have been lost to millions of people in the country. The central government had also issued strict instructions on vaccine waste from the states. In addition, new shipments are not a priority in those states that have missed the most doses.

This policy needs to be changed

Bharat Biotech President Dr. Krishnan Mela said that the government also faced difficulties due to the low dose of the vaccine. In such a situation, it was necessary to change the policy. His scientists also found a way out after hard work and now the voice of Kovacian will be safe for 28 days.

Now Covishield also needs to be changed

The Covishield vaccine of Poona-based Serum Institute India has been installed in most states of the country. For the capital Delhi, the Covishield vaccine is administered at 400 locations, excluding six central government hospitals alone. Therefore, it is being said that such a change in Coushield's policy should be made as soon as possible to eliminate wastage of vaccine supplements. However, according to information received by the institute, scientists from Oxford University are working in this direction.

What the figures say

. The coronavirus vaccine has been established in 15.52 million people so far.

. 1,45,41,467 people get cattle from India Biotech

. 14,06,95,671 people are employed in the Covishield vaccine.

. Only the Covishield vaccine is available in 16 states. Rs60 crore loss due to vaccine malfunction.